[Pituitary adrenocortical response to high dose administration of betamethasone in neurosurgical patients (author's transl)]. 1980

T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume

Using RIA technique, response patterns of ACTH-adrenocortical system to short term large dose corticosteroid therapy for neurosurgical patients were investigated. The subjects were consisted of 20 males and 13 females, ageing ranging from 10 to 60 years old. The subjects were divided into three groups according to mode of steroid administration. In the first group, 12 mg/day of betamethasone were administered for 5 days and cancelled without gradual reduction. In the second group, 12 mg/day of betamethasone were administered for 4 days and 6 mg/day of betamethasone were given for following 2 days. In the third group, 12 mg/day of betamethasone were administered for 3 days and gradual reduction of betamethasone was given for following 4-5 days. Response of plasma cortisol level to synthetic 18-ACTH were measured in all patients for 3 days after betamethasone administration cancelled. The results led to the following conclusion. 1) The second and third groups had not any clinical symptom after steroid cancelled, but one half cases of the first group had mild headache, nausea for 2 days after cancelled. 2) Recovery process of adrenocortical function in the second group is most rapidly, compared with that in other two groups. 3) In the postoperative steroid therapy in neurosurgery, it could be concluded that 4 days massive administration of steroid followed by stepwise reduction in 2 days would be functionally well tolerated by adrenocortical system.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
April 1979, Horumon to rinsho. Clinical endocrinology,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
August 1980, Deutsche medizinische Wochenschrift (1946),
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
January 1973, Annales d'endocrinologie,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
July 1979, Horumon to rinsho. Clinical endocrinology,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
January 1976, Rinsho byori. The Japanese journal of clinical pathology,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
January 1977, No shinkei geka. Neurological surgery,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
February 1975, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
August 1981, Masui. The Japanese journal of anesthesiology,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
August 1979, Masui. The Japanese journal of anesthesiology,
T Ohkubo, and O Kubo, and M Jimbo, and K Kitamura, and H Demura, and R Demura, and K Shizume
November 1980, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Copied contents to your clipboard!